The global Arrhythmia Monitoring Devices Market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.
Big
pharma and medical device companies are heavily investing in R&D to perform
a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received
FDA clearance for the first non-invasive cardiac mapping system, CardioInsight.
It includes wearable 252-electrode sensor vest that creates 3D electroanatomic
maps of heart by combining data from a cardiac computed tomography scan with
ECG signals collected from the chest region.
In
addition to these technologies, emergence and advancements in mobile cardiac
telemetry are leading to further progress of the overall market. In October
2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible
implantable cardiac monitor indicated for arrhythmia diagnosis. Boston
Scientific announced its FDA approval for Resonate, a line of cardiac
resynchronization therapy defibrillator and cardioverter defibrillator systems
for the cardiac management.
Request
a free sample copy or view report summary: Arrhythmia Monitoring Devices Market Report
Arrhythmia
Monitoring Devices Market Report Highlights
- The
arrhythmia monitoring devices market is highly competitive and is rapidly
evolving with numerous potential market players
- Holter
monitors dominated the market in terms of revenue in 2017. On the other
hand, mobile cardiac telemetry is expected to witness the fastest growth
rate during the forecast period
- Atrial
fibrillation dominated the market in terms of revenue in 2017. The growth
in the number of untreated cases of arrhythmias are leading to increasing
need for advanced cardiac monitoring devices
- Heightened
adoption of sophisticated technologies has led to the expansion of the
market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting
the heart rhythm for conditions such as atrial fibrillation
- The
hospitals and clinics segment held the largest share in the market in
2017. On the other hand, diagnostic centers are likely to experience the
fastest growth over the forecast period
- North
America commanded the leading share in the market in 2017 due to faster
regulatory approvals for innovative devices and procedures
- AliveCor,
Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda
Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical
(Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs
Healthcare are some of the key players operating in this market.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment